首页> 外国专利> PYRAZOLOPYRIMIDINONS INHIBITING CYCLIC GUANOSINE 3', 5'-MONOPHOSPHATE PHOSPHODIESTERASE TYPE 5 (cGMP PDE5), FOR THE TREATMENT OF SEXUAL DYSFUNCTION

PYRAZOLOPYRIMIDINONS INHIBITING CYCLIC GUANOSINE 3', 5'-MONOPHOSPHATE PHOSPHODIESTERASE TYPE 5 (cGMP PDE5), FOR THE TREATMENT OF SEXUAL DYSFUNCTION

机译:吡唑并吡嗪酮抑制5'环磷酸鸟苷磷酸酶5型(cGMP PDE5),用于治疗性功能障碍

摘要

The compounds are powerful and selective cGMP PDE5 inhibitors, useful in the threatment of male erection and female sexual dysfunction. They have the formulae where R1 is C1 to C3 alkyl substituted with C3 to C6 cycloalkyl, CONR5R6 or N-bound heterocyclic group; (CH2)nHet or (CH2)nAr; R2 is C1 to C6 alkyl; R3 is C1 to C6 alkyl optionally substituted with C1-C4 alkoxy; R4 is SO2NR7R8; R5 and R6 are independently selected from H and C1 to C4 alkyl, optionally substituted with C1 to C4 alkoxy or together with the nitrogen atom to which they are adjuncted form 5- or 6-member heterocaclic group; R7 & R8 together with the nitrogen atom to which they are adjuncted for 4-R10-piperazinyl group; R10 is H, or C1 to C4 alkyl optionally substituted with OH, C1 to C4 alkoxy or CONH2; Het is optionally substituted C-bound 5- or 6-member heterocyclic group, Ar is optionally substituted; and n has the value of 0 or 1. The invention also relates to veterinary acceptable salts and solvates of the above compounds. 18 claims
机译:这些化合物是有效的选择性cGMP PDE5抑制剂,可用于威胁男性勃起和女性性功能障碍。它们具有下式:其中R 1为被C 3至C 6环烷基,CONR 5 R 6或N键合的杂环基取代的C 1至C 3烷基; (CH2)nHet或(CH2)nAr; R2为C1-C6烷基; R3是任选地被C1-C4烷氧基取代的C1-C6烷基; R4为SO2NR7R8; R 5和R 6独立地选自H和C 1 -C 4烷基,任选地被C 1 -C 4烷氧基取代或与它们所邻接的氮原子一起形成5或6元杂环基。 R7和R8与它们所邻接的氮原子一起为4-R10-哌嗪基; R10为H,或任选被OH,C1至C4烷氧基或CONH2取代的C1至C4烷基; Het为任选取代的C键联的5或6元杂环基团,Ar为任选取代的; n为0或1。本发明还涉及上述化合物的兽医学上可接受的盐和溶剂化物。 18项索赔

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号